Preclinical imaging developer MILabs has taken an order for its Vector PET/SPECT/CT from Tel Aviv University's new Translational Medicine Center.
The system will be installed at Sackler Cellular and Molecular Imaging Center, which will serve as the university's core imaging facility.
The center's plan is to use the system to support the country's drug industry by accelerating discoveries into the clinic.
